p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor

Core Insights - A partnership has been established between p-Chip Corporation, Choice One Rx, and RxERP to conduct a trial for end-to-end digital traceability in pharmaceutical supply chains, focusing on Oncology, Urology, Rheumatology, and Gastroenterology for over 1,000 patients until 2028 [1][2] - The trial aims to validate compliance with the U.S. Drug Supply Chain Security Act (DSCSA) by establishing verifiable Chain-of-Identity and Chain-of-Custody for individual prescriptions [1][4] Group 1: Trial Objectives and Technology - The trial will utilize p-Chip's Light Activated Microtransponders (MTPs) embedded in prescription vials to enable unit-level serialization, providing a secure and unique digital ID for traceability [2][4] - Unlike traditional labeling methods, which are susceptible to damage and counterfeiting, the MTPs offer a tamper-resistant solution that maintains a continuous connection between a drug's physical form and its digital record [3][4] Group 2: Compliance and Operational Feasibility - The trial will validate operational feasibility in a live pharmacy environment through Choice One Rx, while RxERP will provide the necessary infrastructure for compliance and reporting [5][6] - The integration of unit-level digital identity into pharmacy systems is expected to enhance interoperability and identity continuity, which are crucial for scalable DSCSA compliance [6][7] Group 3: Broader Implications and Future Goals - The initiative is seen as a foundational effort to improve supply chain capabilities, including counterfeit detection, diversion prevention, and automated recalls, thereby enhancing product confidence [8][9] - By demonstrating digital traceability and Chain-of-Identity, the trial aims to inspire industry-wide adoption of secure supply chain technologies, ultimately supporting regulatory efforts to protect patient health and safety [9]